Search Back New search Go to resultsDiseaseMain groupSolid TumorsSupportive Therapy, ToxicityProtocol groupComplicationsGynecological OncologyDiseaseBone MetastasesOsteolysisSubgroupICD10C79.5M89.5-MeSHOsteolysisSequenceChemotherapyChemo-substanceChemo-substanceChemo-substanceChemo-substanceNo. Substances RadiotherapySupportive therapySupportive substanceIbandron AcidSupportive substanceIbandron AcidSupportive substanceIbandron AcidSupportive substanceIbandron AcidNo. Substances1Protocol classificationTherapy classificationalternativeIntensityStandard doseTherapy indicationTherapy phaseTherapy intentionsupportiveRisksCardiotoxicityCataractDiarrheaHypocalcemiaOsteonecrosis of the Jaw only studiesPublicationAuthorBody JDiseaseMamma-Ca mit Knochenmetastasen, ECOG 0-2Mamma-Ca mit Knochenmetastasen, ECOG 0-3OriginUniversité Libre de Bruxelles, Institut Jules Bordet, Brussels, BelgiumUniversité Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium, MF 4265 Study GroupProtocols in Revision 2 protocols foundProtocols under revision.IbandronAcid 50, Bone Metastases (PID948 V1.0)IbandronAcid 6, Bone Metastases (PID937 V1.0)
